Barclays
NUVB icon

Barclays’s Nuvation Bio NUVB Stock Holding History

Barclays’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$491K Sell
114,491
-324,781
-74% -$1.81M ﹤0.01% 3199
2025
Q4 		$3.94M Sell
439,272
-56,662
-11% -$351K ﹤0.01% 2406
2025
Q3 		$1.83M Sell
495,934
-523,631
-51% -$1.43M ﹤0.01% 2948
2025
Q2 		$1.99M Sell
1,019,565
-330,198
-24% -$688K ﹤0.01% 2849
2025
Q1 		$2.38M Buy
1,349,763
+70,051
+5% +$159K ﹤0.01% 2499
2024
Q4 		$3.4M Buy
1,279,712
+61,391
+5% +$158K ﹤0.01% 2475
2024
Q3 		$2.79M Sell
1,218,321
-333,817
-22% -$1.02M ﹤0.01% 2579
2024
Q2 		$4.53M Sell
1,552,138
-53,568
-3% -$163K ﹤0.01% 1607
2024
Q1 		$5.84M Buy
1,605,706
+1,118,954
+230% +$2.15M ﹤0.01% 1748
2023
Q4 		$735K Buy
486,752
+384,443
+376% +$495K ﹤0.01% 3650
2023
Q3 		$137K Sell
102,309
-2,845
-3% -$4.74K ﹤0.01% 3468
2023
Q2 		$189K Sell
105,154
-119,324
-53% -$203K ﹤0.01% 3273
2023
Q1 		$373K Buy
224,478
+156,016
+228% +$316K ﹤0.01% 3462
2022
Q4 		$131K Buy
68,462
+11,909
+21% +$24.1K ﹤0.01% 4068
2022
Q3 		$127K Buy
56,553
+3,377
+6% +$9.64K ﹤0.01% 3427
2022
Q2 		$172K Sell
53,176
-7,746
-13% -$33.8K ﹤0.01% 3521
2022
Q1 		$321K Buy
+60,922
New +$342K ﹤0.01% 3172

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays's NUVB Position: Q1 2026 in Review

Barclays reduced its Nuvation Bio (NUVB) stake by 74% in Q1 2026, selling an estimated $1.81M and leaving 114,491 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #3199.

Barclays first reported a position in NUVB in Q1 2022 and has held it in 17 quarters since. The position peaked at $5.84M in Q1 2024. 233 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Barclays held 114,491 shares of Nuvation Bio worth $491K as of Q1 2026.
  • Barclays sold 324,781 Nuvation Bio shares in Q1 2026, an estimated $1.81M.
  • Nuvation Bio made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3199 holding.
  • Barclays first reported a position in Nuvation Bio in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Nuvation Bio position peaked at $5.84M in Q1 2024.
  • 233 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.